Potential Application of Chimeric Antigen Receptor (CAR)-T Cell Therapy in Renal Cell Tumors

Currently, renal cell carcinoma is characterized by encouraging benefits from immunotherapy that have led to significant results in treatment outcome. The approval of nivolumab primarily as second-line monotherapy and, more recently, the approval of new combination therapies as first-line treatment...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Front Oncol
Main Authors: Schepisi, Giuseppe, Conteduca, Vincenza, Casadei, Chiara, Gurioli, Giorgia, Rossi, Lorena, Gallà, Valentina, Cursano, Maria Concetta, Brighi, Nicole, Lolli, Cristian, Menna, Cecilia, Farolfi, Alberto, Burgio, Salvatore Luca, Altavilla, Amelia, Martinelli, Giovanni, De Giorgi, Ugo
Formato: Artigo
Idioma:Inglês
Publicado em: Frontiers Media S.A. 2020
Assuntos:
Oncology
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC7538692/
https://ncbi.nlm.nih.gov/pubmed/33072597
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3389/fonc.2020.565857
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados